-
(单词翻译:双击或拖选)
Script:
Well, er, third straight day of solid gains on Wall Streets. Stephanie Elam is in New York, with a look at the markets and the rest of our business headlines. You are bringing us good luck, Stephanie?
I am bringing you at least good news; I'm not fond of good luck, but good news. We will take that, right? Well, it has to do with inflation, and it sparked today's rally. The consumer price index actually jumped seven tenths of a percent in May. But investors1 focused on what is known as the core rate. That strips out the volatile2 food and energy sectors3, and it showed a minimum increase of just one tenth of a percent. That indicates that the big jump in food and energy this year is not spilling over to other sectors of the economy. So let’s take a look at the numbers as they finally settled down. Here at the Dow up 85 points, up better than half a percent at 13,639. The NASDAQ better by 27 points, that's enough to push it over a gain of one percent. And the S&P 500, up 9 points, and that's solidly above half a percentage gain there as well. Now, taking a look at the Dow and the S&P, which have set a series of record highs recently. The NASDAQ is still 48 percent below the record it set, way back in March of 2000, just before the Internet bubble burst. So while we are seeing some gains, there is still, you know, it’s not. com day.
You gotta to keep it sober, don’t you?
I have to, I got to keep everything, you know, within realm of reality.
OK, we appreciate that. Drug stores and diet pills, there is a new one out there, not necessarily new news though, is it?
Well, right. This is, it's called Alli. Some people have heard of it. And it’s the first over-the-counter weight-loss supplement approved by the Food and Drug Administration. Retailers4 across the country began offering the drug today. So this is the first time we can actually get it. And some earlier reports indicate the product is practically flying off the shelves. No surprise there. The pill is made by GlaxoSmithKline which also sells the prescription5 version of the pill, which is Xenical. So it’s not really new, but this is the over-the-counter version. The drug maker6 are so exited about the over-the-counter version; it is spending a reported 150 million dollars on advertising7. The drug sells for approximately a dollar eighty a day. Experts have taken a wait-and-see approach regarding the diet drug. Some are skeptical8 about how effective an over-the-counter-version of the prescription drug will be. Alli is supposed to work by blocking the amount of fat absorbed by the bodies. So maybe if you cut out one of those coffee drinks a day, it will be cheaper for you to take the diet pill. I don't know.
That's right. Diet pill economics, so Stephanie Elam. Tie there.
It's gonna be my podcast.
Speak of podcast, let’s talk. We can’t have a discussion, right? As we walk up to the introduction of the iPhone on the 29th, I think we've got like 15 days. So we, I understand we've got another iPhone angle. It’s not only necessarily a winner for Apple, but also AT&T.
Right, and this is all iPhone, all the time for Richard. And if the iPhone is as big a success as many analysts9 expected to be. AT&T would be a big winner. In order to get phone service, yeah, you have to subscribe10 to AT&T's wireless11 service. And that does not seem to be scaring away potential customers. A pair of new survey shows that about two thirds of mobile phone users who are interested in buying the iPhone are not AT&T customers now, but would be willing to make the switch. M:Metrics says, T-mobile has the most to be worried about, since it has a lot of subscribers who are under the age of 25. And of course, that’s likely to be a big iPhone customer base. The two versions on the iPhone will cost either $499 or $599, all about storage there. Still Apple expects to sell 10 million of the devices by the end of next year. And I can pretty much guarantee that one will be going out in 15 days, to my friend Richard.
If I say it enough, I am hoping, I am hoping here, Stephanie that something will happen. You got a big plan for the weekend?
I do, I am going home to California.
I am too. We will see there.
You are?
Yes, I am. Ma'am
Ok, I will look for you.
We will talk later.
Ok.
Alright, Stephanie Elam in New York thanks again.
Have a good one.
You too.
notes:
Over-the-counter: adj.
also known as OTC, may refer to:
Over-the-counter drugs are medicines that may be sold without a prescription and without a visit to a medical professional, in contrast to prescription drugs.
Over-the-counter financial instruments, such as stocks, exchanged directly between two parties.
iPhone:
The iPhone is a multimedia12 and Internet-enabled mobile phone by Apple. The iPhone's functions include those of a camera phone, a multimedia player, and mobile phone. It also offers Internet services including e-mail, text messaging, web browsing13, Visual Voicemail, and local Wi-Fi connectivity.
GlaxoSmithKline:
GlaxoSmithKline plc is a British based pharmaceutical14, biologicals, and healthcare company. GSK is a research-based company with a wide portfolio15 of pharmaceutical products covering anti-infectives, central nervous system (CNS), respiratory, gastro-intestinal/metabolic, oncology and vaccines16 products. It also has a Consumer Healthcare operation comprising leading oral healthcare products, nutritional17 drinks and over the counter (OTC) medicines.
Well, er, third straight day of solid gains on Wall Streets. Stephanie Elam is in New York, with a look at the markets and the rest of our business headlines. You are bringing us good luck, Stephanie?
I am bringing you at least good news; I'm not fond of good luck, but good news. We will take that, right? Well, it has to do with inflation, and it sparked today's rally. The consumer price index actually jumped seven tenths of a percent in May. But investors1 focused on what is known as the core rate. That strips out the volatile2 food and energy sectors3, and it showed a minimum increase of just one tenth of a percent. That indicates that the big jump in food and energy this year is not spilling over to other sectors of the economy. So let’s take a look at the numbers as they finally settled down. Here at the Dow up 85 points, up better than half a percent at 13,639. The NASDAQ better by 27 points, that's enough to push it over a gain of one percent. And the S&P 500, up 9 points, and that's solidly above half a percentage gain there as well. Now, taking a look at the Dow and the S&P, which have set a series of record highs recently. The NASDAQ is still 48 percent below the record it set, way back in March of 2000, just before the Internet bubble burst. So while we are seeing some gains, there is still, you know, it’s not. com day.
You gotta to keep it sober, don’t you?
I have to, I got to keep everything, you know, within realm of reality.
OK, we appreciate that. Drug stores and diet pills, there is a new one out there, not necessarily new news though, is it?
Well, right. This is, it's called Alli. Some people have heard of it. And it’s the first over-the-counter weight-loss supplement approved by the Food and Drug Administration. Retailers4 across the country began offering the drug today. So this is the first time we can actually get it. And some earlier reports indicate the product is practically flying off the shelves. No surprise there. The pill is made by GlaxoSmithKline which also sells the prescription5 version of the pill, which is Xenical. So it’s not really new, but this is the over-the-counter version. The drug maker6 are so exited about the over-the-counter version; it is spending a reported 150 million dollars on advertising7. The drug sells for approximately a dollar eighty a day. Experts have taken a wait-and-see approach regarding the diet drug. Some are skeptical8 about how effective an over-the-counter-version of the prescription drug will be. Alli is supposed to work by blocking the amount of fat absorbed by the bodies. So maybe if you cut out one of those coffee drinks a day, it will be cheaper for you to take the diet pill. I don't know.
That's right. Diet pill economics, so Stephanie Elam. Tie there.
It's gonna be my podcast.
Speak of podcast, let’s talk. We can’t have a discussion, right? As we walk up to the introduction of the iPhone on the 29th, I think we've got like 15 days. So we, I understand we've got another iPhone angle. It’s not only necessarily a winner for Apple, but also AT&T.
Right, and this is all iPhone, all the time for Richard. And if the iPhone is as big a success as many analysts9 expected to be. AT&T would be a big winner. In order to get phone service, yeah, you have to subscribe10 to AT&T's wireless11 service. And that does not seem to be scaring away potential customers. A pair of new survey shows that about two thirds of mobile phone users who are interested in buying the iPhone are not AT&T customers now, but would be willing to make the switch. M:Metrics says, T-mobile has the most to be worried about, since it has a lot of subscribers who are under the age of 25. And of course, that’s likely to be a big iPhone customer base. The two versions on the iPhone will cost either $499 or $599, all about storage there. Still Apple expects to sell 10 million of the devices by the end of next year. And I can pretty much guarantee that one will be going out in 15 days, to my friend Richard.
If I say it enough, I am hoping, I am hoping here, Stephanie that something will happen. You got a big plan for the weekend?
I do, I am going home to California.
I am too. We will see there.
You are?
Yes, I am. Ma'am
Ok, I will look for you.
We will talk later.
Ok.
Alright, Stephanie Elam in New York thanks again.
Have a good one.
You too.
notes:
Over-the-counter: adj.
also known as OTC, may refer to:
Over-the-counter drugs are medicines that may be sold without a prescription and without a visit to a medical professional, in contrast to prescription drugs.
Over-the-counter financial instruments, such as stocks, exchanged directly between two parties.
iPhone:
The iPhone is a multimedia12 and Internet-enabled mobile phone by Apple. The iPhone's functions include those of a camera phone, a multimedia player, and mobile phone. It also offers Internet services including e-mail, text messaging, web browsing13, Visual Voicemail, and local Wi-Fi connectivity.
GlaxoSmithKline:
GlaxoSmithKline plc is a British based pharmaceutical14, biologicals, and healthcare company. GSK is a research-based company with a wide portfolio15 of pharmaceutical products covering anti-infectives, central nervous system (CNS), respiratory, gastro-intestinal/metabolic, oncology and vaccines16 products. It also has a Consumer Healthcare operation comprising leading oral healthcare products, nutritional17 drinks and over the counter (OTC) medicines.
点击
收听单词发音
收听单词发音 |
1
investors
|
|
| n.投资者，出资者( investor的名词复数 ) | |
参考例句： |
|
|
|
|
2
volatile
|
|
| adj.反复无常的，挥发性的，稍纵即逝的，脾气火爆的；n.挥发性物质 | |
参考例句： |
|
|
|
|
3
sectors
|
|
| n.部门( sector的名词复数 )；领域；防御地区；扇形 | |
参考例句： |
|
|
|
|
4
retailers
|
|
| 零售商，零售店( retailer的名词复数 ) | |
参考例句： |
|
|
|
|
5
prescription
|
|
| n.处方，开药；指示，规定 | |
参考例句： |
|
|
|
|
6
maker
|
|
| n.制造者，制造商 | |
参考例句： |
|
|
|
|
7
advertising
|
|
| n.广告业；广告活动 a.广告的；广告业务的 | |
参考例句： |
|
|
|
|
8
skeptical
|
|
| adj.怀疑的，多疑的 | |
参考例句： |
|
|
|
|
9
analysts
|
|
| 分析家，化验员( analyst的名词复数 ) | |
参考例句： |
|
|
|
|
10
subscribe
|
|
| vi.(to)订阅，订购；同意；vt.捐助，赞助 | |
参考例句： |
|
|
|
|
11
wireless
|
|
| adj.无线的；n.无线电 | |
参考例句： |
|
|
|
|
12
multimedia
|
|
| adj.多种手段的，多媒体的；n.多媒体 | |
参考例句： |
|
|
|
|
13
browsing
|
|
| v.吃草( browse的现在分词 )；随意翻阅；（在商店里）随便看看；（在计算机上）浏览信息 | |
参考例句： |
|
|
|
|
14
pharmaceutical
|
|
| adj.药学的，药物的；药用的，药剂师的 | |
参考例句： |
|
|
|
|
15
portfolio
|
|
| n.公事包；文件夹；大臣及部长职位 | |
参考例句： |
|
|
|
|
16
vaccines
|
|
| 疫苗，痘苗( vaccine的名词复数 ) | |
参考例句： |
|
|
|
|
17
nutritional
|
|
| adj.营养的，滋养的 | |
参考例句： |
|
|
|
购买
在百度中搜索